Blood pressure regulation in stress: focus on nitric oxide-dependent mechanisms
Language English Country Czech Republic Media print
Document type Journal Article, Review
PubMed
27775419
DOI
10.33549/physiolres.933442
PII: 933442
Knihovny.cz E-resources
- MeSH
- Mechanotransduction, Cellular MeSH
- Gasotransmitters metabolism MeSH
- Glucocorticoids metabolism MeSH
- Hypertension etiology physiopathology MeSH
- Blood Pressure MeSH
- Humans MeSH
- Models, Cardiovascular MeSH
- Nitric Oxide metabolism MeSH
- Stress, Psychological complications physiopathology MeSH
- Muscle, Smooth, Vascular physiopathology MeSH
- Sympathetic Nervous System physiopathology MeSH
- Vasodilation MeSH
- Vasomotor System physiopathology MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Gasotransmitters MeSH
- Glucocorticoids MeSH
- Nitric Oxide MeSH
Stress is considered a risk factor associated with the development of various civilization diseases including cardiovascular diseases, malignant tumors and mental disorders. Research investigating mechanisms involved in stress-induced hypertension have attracted much attention of physicians and researchers, however, there are still ambiguous results concerning a causal relationship between stress and long-term elevation of blood pressure (BP). Several studies have observed that mechanisms involved in the development of stress-induced hypertension include increased activity of sympathetic nervous system (SNS), glucocorticoid (GC) overload and altered endothelial function including decreased nitric oxide (NO) bioavailability. Nitric oxide is well known neurotransmitter, neuromodulator and vasodilator involved in regulation of neuroendocrine mechanisms and cardiovascular responses to stressors. Thus NO plays a crucial role in the regulation of the stress systems and thereby in the BP regulation in stress. Elevated NO synthesis, especially in the initial phase of stress, may be considered a stress-limiting mechanism, facilitating the recovery from stress to the resting levels via attenuation of both GC release and SNS activity as well as by increased NO-dependent vasorelaxation. On the other hand, reduced levels of NO were observed in the later phases of stress and in subjects with genetic predisposition to hypertension, irrespectively, in which reduced NO bioavailability may account for disruption of NO-mediated BP regulatory mechanisms and accentuated SNS and GC effects. This review summarizes current knowledge on the role of stress in development of hypertension with a special focus on the interactions among NO and other biological systems affecting blood pressure and vascular function.
References provided by Crossref.org